Amy Boldosser-Boesch is senior director and head of the FCI Program of MSH within the Health Programs Group, based in MSH's New York office. Amy leads the FCI Program of MSH team's advocacy and accountability work for improved reproductive, maternal, newborn, and adolescent health and for access to universal health coverage.
Judith Seltzer is the Senior Director of the Performance, Learning and Impact unit at MSH. In this capacity, she leads a team of diverse specialists who provide knowledge management, research, and monitoring and evaluation support across the organization.
Helena Walkowiak is a Principal Technical Advisor for the USAID-funded Medicines, Technologies, and Pharmaceutical Services (MTaPS) Program. She has 17 years of experience in providing technical assistance in pharmaceutical management to health programs in Africa, Asia, Eastern Europe, and the Caribbean. Ms.
Director Technical Strategy and Quality, Pharmaceuticals and Health Technologies Group
David Lee Chin, M.D., is Director Technical Strategy and Quality for the Pharmaceuticals and Health Technologies Group. He has over 30 years of experience in pharmaceutical management, including training, operations research and evaluation, and providing technical assistance to enhance access to and rational use of medicines in Africa, Asia, and the Americas. Dr. Lee is responsible for technical strategy oversight of PHT projects and designing and managing pharmaceutical sector studies. In addition to his medical degree and residency in pediatrics, he is also trained in Clinical Pharmacology.